ArticleJournal of substance abuse treatment2015
Sustained, new, never, and discontinued tobacco cessation services adopters.
Article in Journal of substance abuse treatment, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 13 citations in OpenAlex.
- Examining the Sustained Impact of California's Tobacco Free for Recovery Initiative: Qualitative Perspectives from Program Directors.Substance use & misuse · 2026Article
- Smoking Intervention Practices in Texas Healthcare Centers with Sexual and Gender Minority Patients.Health behavior and policy review · 2022Article
- Implementing tobacco-free policy in residential substance use disorders treatment: Practice changes among staff.Drug and alcohol dependence reports · 2022Article
- Implementation and Outcomes of a Comprehensive Tobacco Free Workplace Program in Opioid Treatment Centers.International journal of environmental research and public health · 2021Article
- Addressing Smoking Cessation among Women in Substance Use Treatment: A Qualitative Approach to Guiding Tailored Interventions.International journal of environmental research and public health · 2021Article
- Review
- Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders.Drug and alcohol dependence · 2018Article
- Barriers and Facilitators to Tobacco Cessation in a Nationwide Sample of Addiction Treatment Programs.Journal of substance abuse treatment · 2016Article
- Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.Psychiatric services (Washington, D.C.) · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
This study examined longitudinal adoption patterns of tobacco cessation (TC) counseling and TC pharmacotherapy in substance use disorder treatment programs and baseline predictors (program characteristics and program culture) of these patterns 12-months later. Telephone survey data were collected in 2010 from 685 randomly sampled program administrators working in geographically representative treatment programs across the U.S. Regarding TC counseling, about 41% of programs never adopt, 33% sustain, and 27% change adoption patterns. Concerning TC pharmacotherapy, about 62% of programs never adopt, 19% sustain, and 18% change adoption patterns. The three most consistent predictors of counseling adoption patterns are TC reimbursement, TC financial resource availability, and smoking culture. For TC pharmacotherapy adoption patterns, the most consistent predictors include profit status, TC reimbursement, level of care, TC financial resource availability, and smoking culture. Findings provide insights into program characteristics and program culture as both potential barriers and facilitators of longitudinal TCS adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.